Cannabis Pharmacology: The Usual Suspects and a Few Promising Leads

Advances in Pharmacology

Volumn 80, Issue , 2017, Pages 67-134

  Russo, Ethan B ^a   Marcu, Jahan ^b  

^a PHYTECS   (United States)

^b Americans for Safe Access   (United States)

Author keywords

Cannabidiol; Cannabinoid; Cannabis; Flavonoid; Herbal medicine; Pharmacognosy; Pharmacology; Phytochemistry; Terpenoid; Tetrahydrocannabinol

Indexed keywords

CANNABINOID; CANNABIS; SESQUITERPENE;

ANIMAL; ANTIBODY SPECIFICITY; CHEMISTRY; HUMAN; ISOMERISM;

ANIMALS; CANNABINOIDS; CANNABIS; HUMANS; ISOMERISM; ORGAN SPECIFICITY; SESQUITERPENES;

EID: 85020191230     PISSN: 10543589     EISSN: 15578925     Source Type: Book Series    
DOI: 10.1016/bs.apha.2017.03.004     Document Type: Chapter

References (364)

1. Ali, A., Tabanca, N., Demirci, B., Blythe, E.K., Ali, Z., Baser, K.H., et al. Chemical composition and biological activity of four salvia essential oils and individual compounds against two species of mosquitoes. Journal of Agricultural and Food Chemistry 63:2 (2015), 447–456 http://doi.org/10.1021/jf504976f.
2. Allegrone, G., Pollastro, F., Magagnini, G., Taglialatela-Scafati, O., Seegers, J., Koeberle, A., et al. The bibenzyl canniprene inhibit the production of pro-inflammatory eicosanoids and selectively accumulates in some cannabis strains. Journal of Natural Products 80:3 (2017), 731–734 http://dx.doi.org/10.1021/acs.jnatprod.6b01126.
3. Alozie, S.O., Martin, B.R., Harris, L.S., Dewey, W.L., 3H-Δ9-tetrahydrocannabinol, 3H-cannabinol and 3H-cannabidiol: Penetration and regional distribution in rat brain. Pharmacology, Biochemistry, and Behavior 12:2 (1980), 217–221 http://doi.org/10.1016/0091-3057(80)90359-7.
4. Americans for Safe Access, Medical access to cannabis for pain treatment. 2016 Retrieved January 3, 2017, from http://www.safeaccessnow.org/medical_cannabis_access_for_pain_treatment.
5. Antonisamy, P., Duraipandiyan, V., Aravinthan, A., Al-Dhabi, N.A., Ignacimuthu, S., Choi, K.C., et al. Protective effects of friedelin isolated from Azima tetracantha Lam. against ethanol-induced gastric ulcer in rats and possible underlying mechanisms. European Journal of Pharmacology 750 (2015), 167–175 http://doi.org/10.1016/j.ejphar.2015.01.015.
6. Antonisamy, P., Duraipandiyan, V., Ignacimuthu, S., Anti-inflammatory, analgesic and antipyretic effects of friedelin isolated from Azima tetracantha Lam. in mouse and rat models. Journal of Pharmacy and Pharmacology 63:8 (2011), 1070–1077 http://doi.org/10.1111/j.2042-7158.2011.01300.x.
7. Appendino, G., Gibbons, S., Giana, A., Pagani, A., Grassi, G., Stavri, M., et al. Antibacterial cannabinoids from cannabis sativa: A structure–activity study. Journal of Natural Products 71:8 (2008), 1427–1430 http://doi.org/10.1021/np8002673.
8. Arruda, D.C., D'Alexandri, F.L., Katzin, A.M., Uliana, S.R., Antileishmanial activity of the terpene nerolidol. Antimicrobial Agents and Chemotherapy 49:5 (2005), 1679–1687.
9. Asakura, K., Kanemasa, T., Minagawa, K., Kagawa, K., Yagami, T., Nakajima, M., et al. alpha-eudesmol, a P/Q-type Ca(2 +) channel blocker, inhibits neurogenic vasodilation and extravasation following electrical stimulation of trigeminal ganglion. Brain Research 873:1 (2000), 94–101.
10. Aydin, E., Turkez, H., Tasdemir, S., Anticancer and antioxidant properties of terpinolene in rat brain cells. Arhiv za Higijenu Rada i Toksikologiju 64:3 (2013), 415–424 http://doi.org/10.2478/10004-1254-64-2013-2365.
11. Backes, M., Cannabis pharmacy: The practical guide to medical marijuana. 2014, Black Dog & Leventhal, New York.
12. Baek, S., Kim, Y.O., Kwag, J.S., Choi, K.E., Jung, W.Y., Han, D.S., Boron trifluoride etherate on silica-A modified Lewis acid reagent (VII). Antitumor activity of cannabigerol against human oral epitheloid carcinoma cells. Archives of Pharmacal Research 21:3 (1998), 353–356.
13. Bahi, A., Al Mansouri, S., Al Memari, E., Al Ameri, M., Nurulain, S.M., Ojha, S., β-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice. Physiology & Behavior 135C (2014), 119–124 http://doi.org/10.1016/j.physbeh.2014.06.003.
14. Bai, J., Zheng, Y., Wang, G., Liu, P., Protective effect of D-limonene against oxidative stress-induced cell damage in human lens epithelial cells via the p38 pathway. Oxidative Medicine and Cellular Longevity, 2016, 2016, 5962832 http://doi.org/10.1155/2016/5962832.
15. Baldissera, M.D., Grando, T.H., Souza, C.F., Gressler, L.T., Stefani, L.M., da Silva, A.S., et al. In vitro and in vivo action of terpinen-4-ol, gamma-terpinene, and alpha-terpinene against Trypanosoma evansi. Experimental Parasitology 162 (2016), 43–48 http://doi.org/10.1016/j.exppara.2016.01.004.
16. Balvers, M.G.J., Verhoeckx, K.C.M., Bijlsma, S., Rubingh, C.M., Meijerink, J., Wortelboer, H.M., et al. Fish oil and inflammatory status alter the n-3 to n-6 balance of the endocannabinoid and oxylipin metabolomes in mouse plasma and tissues. Metabolomics: Official Journal of the Metabolomic Society 8:6 (2012), 1130–1147 http://doi.org/10.1007/s11306-012-0421-9.
17. Banerjee, S.P., Snyder, S.H., Mechoulam, R., Cannabinoids: Influence on neurotransmitter uptake in rat brain synaptosomes. Journal of Pharmacology and Experimental Therapeutics 194:1 (1975), 74–81.
18. Barbosa, L.C., Filomeno, C.A., Teixeira, R.R., Chemical variability and biological activities of Eucalyptus spp. essential oils. Molecules (Basel, Switzerland), 21(12), 2016, 33 http://doi.org/10.3390/molecules21121671.
19. Barrett, M.L., Scutt, A.M., Evans, F.J., Cannflavin A and B, prenylated flavones from Cannabis sativa L. Experientia 42:4 (1986), 452–453.
20. Baser, K.H.C., Buchbauer, G., Handbook of essential oils: Science, technology, and applications. 2nd ed., 2016, CRC Press, Boca Raton, FL.
21. Batista, P.A., de Paula Werner, M.F., Oliveira, E.C., Burgos, L., Pereira, P., da Silva Brum, L.F., et al. The antinociceptive effect of (-)-linalool in models of chronic inflammatory and neuropathic hypersensitivity in mice. The Journal of Pain 11:11 (2010), 1222–1229 http://doi.org/10.1016/j.jpain.2010.02.022.
22. Batista, P.A., Werner, M.F., Oliveira, E.C., Burgos, L., Pereira, P., Brum, L.F., et al. Evidence for the involvement of ionotropic glutamatergic receptors on the antinociceptive effect of (-)-linalool in mice. Neuroscience Letters 440:3 (2008), 299–303 http://doi.org/10.1016/j.neulet.2008.05.092.
23. Ben Amar, M., Cannabinoids in medicine: A review of their therapeutic potential. Journal of Ethnopharmacology 105:1–2 (2006), 1–25 http://doi.org/10.1016/j.jep.2006.02.001.
24. Ben Sghaier, M., Mousslim, M., Pagano, A., Ammari, Y., Luis, J., Kovacic, H., beta-Eudesmol, a sesquiterpene from Teucrium ramosissimum, inhibits superoxide production, proliferation, adhesion and migration of human tumor cell. Environmental Toxicology and Pharmacology 46 (2016), 227–233 http://doi.org/10.1016/j.etap.2016.07.019.
25. Bento, A.F., Marcon, R., Dutra, R.C., Claudino, R.F., Cola, M., Leite, D.F.P., et al. β-Caryophyllene inhibits dextran sulfate sodium-induced colitis in mice through CB2 receptor activation and PPARγ pathway. The American Journal of Pathology 178:3 (2011), 1153–1166 http://doi.org/10.1016/j.ajpath.2010.11.052.
26. Bettarini, F., Borgonovi, G.E., Fiorani, T., Gagliardi, I., Caprioli, V., Massardo, P., et al. Antiparasitic compounds from East African plants: Isolation and biological activity of anonaine, matricarianol, canthin-6-one, and caryophyllene oxide. Insect Science and Its Application 14:1 (1993), 93–99.
27. Bhatia, S.P., Letizia, C.S., Api, A.M., Fragrance material review on alpha-terpineol. Food Chem Toxicol 46:Suppl. 11 (2008), S280–S285 http://doi.org/10.1016/j.fct.2008.06.027.
28. Bhatia, S.P., McGinty, D., Letizia, C.S., Api, A.M., Fragrance material review on fenchyl alcohol. Food Chem Toxicol 46:Suppl 11 (2008), S157–159, 10.1016/j.fct.2008.06.047.
29. Binet, L., Binet, P., Miocque, M., Roux, M., Bernier, A., Recherches sur les proprietes pharmcodynamiques (action sedative et action spasmolytique) de quelques alcools terpeniques aliphatiques. Annales Pharmaceutiques Françaises 30:9 (1972), 611–616.
30. Bishayee, A., Ahmed, S., Brankov, N., Perloff, M., Triterpenoids as potential agents for the chemoprevention and therapy of breast cancer. Frontiers in Bioscience (Landmark Edition) 16 (2011), 980–996.
31. Bisogno, T., Hanus, L., De Petrocellis, L., Tchilibon, S., Ponde, D.E., Brandi, I., et al. Molecular targets for cannabidiol and its synthetic analogues: Effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. The British Journal of Pharmacology 134:4 (2001), 845–852.
32. Bisset, N.G., Wichtl, M., Herbal drugs and phytopharmaceuticals: A handbook for practice on a scientific basis. 3rd ed., 2004, Medpharm Scientific Publishers; CRC Press, Stuttgart, Boca Raton.
33. Bolognini, D., Costa, B., Maione, S., Comelli, F., Marini, P., Di Marzo, V., et al. The plant cannabinoid Delta9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice. British Journal of Pharmacology 160:3 (2010), 677–687 http://doi.org/10.1111/j.1476-5381.2010.00756.x.
34. Bolognini, D., Rock, E.M., Cluny, N.L., Cascio, M.G., Limebeer, C.L., Duncan, M., et al. Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation. British Journal of Pharmacology 168:6 (2013), 1456–1470 http://doi.org/10.1111/bph.12043.
35. Bomfim, D.S., Ferraz, R.P., Carvalho, N.C., Soares, M.B., Pinheiro, M.L., Costa, E.V., et al. Eudesmol isomers induce caspase-mediated apoptosis in human hepatocellular carcinoma HepG2 cells. Basic & Clinical Pharmacology & Toxicology 113:5 (2013), 300–306 http://doi.org/10.1111/bcpt.12097.
36. Bomfim, L.M., Menezes, L.R.A., Rodrigues, A.C.B.C., Dias, R.B., Rocha, C.A.G., Soares, M.B.P., et al. Antitumour activity of the microencapsulation of Annona vepretorum essential oil. Basic & Clinical Pharmacology & Toxicology 118:3 (2016), 208–213 http://doi.org/10.1111/bcpt.12488.
37. Bonamin, F., Moraes, T.M., Dos Santos, R.C., Kushima, H., Faria, F.M., Silva, M.A., et al. The effect of a minor constituent of essential oil from Citrus aurantium: The role of β-myrcene in preventing peptic ulcer disease. Chemico-Biological Interactions 212 (2014), 11–19 http://doi.org/10.1016/j.cbi.2014.01.009.
38. Bonesi, M., Menichini, F., Tundis, R., Loizzo, M.R., Conforti, F., Passalacqua, N.G., et al. Acetylcholinesterase and butyrylcholinesterase inhibitory activity of Pinus species essential oils and their constituents. Journal of Enzyme Inhibition and Medicinal Chemistry 25:5 (2010), 622–628 http://doi.org/10.3109/14756360903389856.
39. Booth, J.K., Page, J.E., Bohlmann, J., Terpene synthases from Cannabis sativa. PLoS ONE, 12(3), 2017, e0173911, 10.1371/journal.pone.0173911.
40. Buchbauer, G., Biological activities of essential oils. Baser, K.H.C., Buchbauer, G., (eds.) Handbook of essential oils: Science, technology, and applications, 2010, CRC Press, Boca Raton, FL, 235–280.
41. Buchbauer, G., Jirovetz, L., Jager, W., Plank, C., Dietrich, H., Fragrance compounds and essential oils with sedative effects upon inhalation. Journal of Pharmaceutical Sciences 82:6 (1993), 660–664.
42. Brown, N.K., Harvey, D.J., In vitro metabolism of cannabichromene in seven common laboratory animals. Drug Metabolism and Disposition 18:6 (1990), 1065–1070.
43. Calhoun, S.R., Galloway, G.P., Smith, D.E., Abuse potential of dronabinol (Marinol). Journal of Psychoactive Drugs 30:2 (1998), 187–196 http://doi.org/10.1080/02791072.1998.10399689.
44. Callaway, J.C., Hempseed as a nutritional resource: An overview. Euphytica 140 (2004), 65–72.
45. Camargos, H.S., Moreira, R.A., Mendanha, S.A., Fernandes, K.S., Dorta, M.L., Alonso, A., Terpenes increase the lipid dynamics in the Leishmania plasma membrane at concentrations similar to their IC50 values. PloS One, 9(8), 2014, e104429 http://doi.org/10.1371/journal.pone.0104429.
46. Campbell, W.E., Gammon, D.W., Smith, P., Abrahams, M., Purves, T.D., Composition and antimalarial activity in vitro of the essential oil of Tetradenia riparia. Planta Medica 63:3 (1997), 270–272.
47. Carrier, E.J., Auchampach, J.A., Hillard, C.J., Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppression. Proceedings of the National Academy of Sciences of the United States of America 103:20 (2006), 7895–7900.
48. Carson, C.F., Riley, T.V., Antimicrobial activity of the major components of the essential oil of Melaleuca alternifolia. The Journal of Applied Bacteriology 78:3 (1995), 264–269.
49. Carvalho-Freitas, M.I., Costa, M., Anxiolytic and sedative effects of extracts and essential oil from Citrus aurantium L. Biological & Pharmaceutical Bulletin 25:12 (2002), 1629–1633.
50. Cascio, M.G., Gauson, L.A., Stevenson, L.A., Ross, R.A., Pertwee, R.G., Evidence that the plant cannabinoid cannabigerol is a highly potent α2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist. British Journal of Pharmacology 159:1 (2010), 129–141 http://doi.org/10.1111/j.1476-5381.2009.00515.x.
51. Cascio, M.G., Pertwee, R.G., Known pharmacological actions of nine nonpsychotropic phytocannabinoids. Pertwee, R.G., (eds.) Handbook of cannabis, 2014, Oxford University Press, Oxford, UK, 137–156 http://doi.org/10.1093/acprof:oso/9780199662685.003.0007.
52. Cascone, P., Iodice, L., Maffei, M.E., Bossi, S., Arimura, G.-I., Guerrieri, E., Tobacco overexpressing β-ocimene induces direct and indirect responses against aphids in receiver tomato plants. Journal of Plant Physiology 173 (2015), 28–32 http://doi.org/10.1016/j.jplph.2014.08.011.
53. Cawthorne, M.A., Wargent, E., Zaibi, M., Stott, C., Wright, S., The CB1 antagonist, delta-9-tetrahydrocannabivarin (THCV) has anti-obesity activity in dietary-induced obese (DIO) mice., Presented at the 17th annual symposium on the cannabinoids, Saint-Sauveur, Quebec, 2007, International Cannabinoid Research Society, Canada, 141.
54. Chandler, R.F., Hooper, S.N., Friedelin and associated triterpenoids. Phytochemistry 18 (1979), 711–724.
55. Chen, T., Hao, J., He, J., Zhang, J., Li, Y., Liu, R., et al. Cannabisin B induces autophagic cell death by inhibiting the AKT/mTOR pathway and S phase cell cycle arrest in HepG2 cells. Food Chemistry 138:2–3 (2013), 1034–1041 http://doi.org/10.1016/j.foodchem.2012.11.102.
56. Chen, W., Liu, Y., Li, M., Mao, J., Zhang, L., Huang, R., et al. Anti-tumor effect of alpha-pinene on human hepatoma cell lines through inducing G2/M cell cycle arrest. Journal of Pharmacological Sciences 127:3 (2015), 332–338 http://doi.org/10.1016/j.jphs.2015.01.008.
57. Chen, T., Wu, Y., Zhang, Y., Wang, B., Hu, Y., Wang, C., et al. Archaeobotanical study of ancient food and cereal remains at the Astana cemeteries, Xinxiang, China. PloS One, 7(9), 2012, e45137 http://doi.org/10.1371/journal.pone.0045137.
58. Chidambara Murthy, K.N., Jayaprakasha, G.K., Patil, B.S., D-limonene rich volatile oil from blood oranges inhibits angiogenesis, metastasis and cell death in human colon cancer cells. Life Sciences 91:11–12 (2012), 429–439 http://doi.org/10.1016/j.lfs.2012.08.016.
59. Chinsembu, K.C., Tuberculosis and nature's pharmacy of putative anti-tuberculosis agents. Acta Tropica 153 (2016), 46–56 http://doi.org/10.1016/j.actatropica.2015.10.004.
60. Chiou, L.C., Ling, J.Y., Chang, C.C., Chinese herb constituent beta-eudesmol alleviated the electroshock seizures in mice and electrographic seizures in rat hippocampal slices. Neuroscience Letters 231:3 (1997), 171–174.
61. Choi, Y.J., Sim, W.C., Choi, H.K., Lee, S.H., Lee, B.H., Alpha-Terpineol induces fatty liver in mice mediated by the AMP-activated kinase and sterol response element binding protein pathway. Food and Chemical Toxicology 55 (2013), 129–136 http://doi.org/10.1016/j.fct.2012.12.025.
62. Choi, H.S., Song, H.S., Ukeda, H., Sawamura, M., Radical-scavenging activities of citrus essential oils and their components: Detection using 1,1-diphenyl-2-picrylhydrazyl. Journal of Agricultural and Food Chemistry 48:9 (2000), 4156–4161.
63. Ciftci, O., Oztanir, M.N., Cetin, A., Neuroprotective effects of β-myrcene following global cerebral ischemia/reperfusion-mediated oxidative and neuronal damage in a C57BL/J6 mouse. Neurochemical Research 39:9 (2014), 1717–1723 http://doi.org/10.1007/s11064-014-1365-4.
64. Clarke, R.C., Merlin, M.D., Cannabis: Evolution and ethnobotany. 2012, University of California Press, Berkeley.
65. Claussen, U., Von Spulak, F., Korte, F., Zur chemischen klassifizierung von pflanzen—XXXI, haschisch—X: Cannabichromen, ein neuer haschisch-inhalts-stoff. Tetrahedron 22:4 (1966), 1477–1479 http://doi.org/10.1016/S0040-4020(01)99445-1.
66. Cluny, N.L., Keenan, C.M., Reimer, R.A., Le Foll, B., Sharkey, K.A., Prevention of diet-induced obesity effects on body weight and gut microbiota in mice treated chronically with delta9-tetrahydrocannabinol. PloS One, 10(12), 2015, e0144270 http://doi.org/10.1371/journal.pone.0144270.
67. Console-Bram, L., Marcu, J., Abood, M.E., Cannabinoid receptors: Nomenclature and pharmacological principles. Progress in Neuro-Psychopharmacology & Biological Psychiatry 38:1 (2012), 4–15 http://doi.org/10.1016/j.pnpbp.2012.02.009.
68. Cornwell, P.A., Barry, B.W., Sesquiterpene components of volatile oils as skin penetration enhancers for the hydrophilic permeant 5-fluorouracil. The Journal of Pharmacy and Pharmacology 46:4 (1994), 261–269.
69. d'Alessio, P.A., Ostan, R., Bisson, J.F., Schulzke, J.D., Ursini, M.V., Bene, M.C., Oral administration of d-limonene controls inflammation in rat colitis and displays anti-inflammatory properties as diet supplementation in humans. Life Sciences 92:24–26 (2013), 1151–1156 http://doi.org/10.1016/j.lfs.2013.04.013.
70. Davis, W.M., Hatoum, N.S., Neurobehavioral actions of cannabichromene and interactions with Δ9-tetrahydrocannabinol. General Pharmacology: The Vascular System 14:2 (1983), 247–252 http://doi.org/10.1016/0306-3623(83)90004-6.
71. DeLong, G.T., Wolf, C.E., Poklis, A., Lichtman, A.H., Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ(9)-tetrahydrocannabinol. Drug and Alcohol Dependence 112:1–2 (2010), 126–133 http://doi.org/10.1016/j.drugalcdep.2010.05.019.
72. de Meijer, E.P.M., Bagatta, M., Carboni, A., Crucitti, P., Moliterni, V.M.C., Ranalli, P., et al. The inheritance of chemical phenotype in Cannabis sativa L. Genetics 163:1 (2003), 335–346.
73. de Meijer, E.P.M., Hammond, K.M., The inheritance of chemical phenotype in Cannabis sativa L. (II): Cannabigerol predominant plants. Euphytica 145 (2005), 189–198.
74. de Meijer, E.P.M., Hammond, K.M., The inheritance of chemical phenotype in Cannabis sativa L. (V): Regulation of the propyl-/pentyl cannabinoid ratio, completion of a genetic model. Euphytica 210:2 (2016), 291–307 http://doi.org/10.1007/s10681-016-1721-3.
75. de Meijer, E.P.M., Hammond, K.M., Micheler, M., The inheritance of chemical phenotype in Cannabis sativa L. (III): Variation in cannabichromene proportion. Euphytica 165 (2009), 293–311.
76. de Meijer, E., & Limited, G. P. (2011). Cannabis sativa plants rich in cannabichromene and its acid, extracts thereof and methods of obtaining extracts there from (12/936,947).
77. de Moura, N.F., Simionatto, E., Porto, C., Hoelzel, S.C., Dessoy, E.C., Zanatta, N., et al. Quinoline alkaloids, coumarins and volatile constituents of Helietta longifoliata. Planta Medica 68:7 (2002), 631–634.
78. de Oliveira, M.G., Marques, R.B., de Santana, M.F., Santos, A.B., Brito, F.A., Barreto, E.O., et al. Alpha-terpineol reduces mechanical hypernociception and inflammatory response. Basic & Clinical Pharmacology & Toxicology 111:2 (2012), 120–125 http://doi.org/10.1111/j.1742-7843.2012.00875.x.
79. De Petrocellis, L., Di Marzo, V., Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: Focus on G-protein-coupled receptors and transient receptor potential channels. Journal of Neuroimmune Pharmacology 5:1 (2010), 103–121 http://doi.org/10.1007/s11481-009-9177-z.
80. De Petrocellis, L., Ligresti, A., Moriello, A.S., Allara, M., Bisogno, T., Petrosino, S., et al. Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. British Journal of Pharmacology 163:7 (2011), 1479–1494, 10.1111/j.1476-5381.2010.01166.x.
81. De Petrocellis, L., Orlando, P., Moriello, A.S., Aviello, G., Stott, C., Izzo, A.A., et al. Cannabinoid actions at TRPV channels: Effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation. Acta Physiologica 204:2 (2012), 255–266 http://doi.org/10.1111/j.1748-1716.2011.02338.x.
82. De Petrocellis, L., Vellani, V., Schiano-Moriello, A., Marini, P., Magherini, P.C., Orlando, P., et al. Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8. The Journal of Pharmacology and Experimental Therapeutics 325:3 (2008), 1007–1015 http://doi.org/10.1124/jpet.107.134809.
83. Deiana, S., Watanabe, A., Yamasaki, Y., Amada, N., Arthur, M., Fleming, S., et al. Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Delta(9)-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour. Psychopharmacology (Berl) 219:3 (2012), 859–873, 10.1007/s00213-011-2415-0.
84. de Lago, E., Fernández-Ruiz, J., Cannabinoids and neuroprotection in motor-related disorders. CNS & Neurological Disorders Drug Targets 6:6 (2007), 377–387 http://doi.org/10.2174/187152707783399210.
85. De-Oliveira, A.C., Ribeiro-Pinto, L.F., Paumgartten, J.R., In vitro inhibition of CYP2B1 monooxygenase by beta-myrcene and other monoterpenoid compounds. Toxicology Letters 92:1 (1997), 39–46 http://doi.org/10.1016/S0378-4274(97)00034-9, S0378427497000349 [pii].
86. do Socorro, S.R.M.S., Mendonca-Filho, R.R., Bizzo, H.R., de Almeida Rodrigues, I., Soares, R.M., Souto-Padron, T., et al. Antileishmanial activity of a linalool-rich essential oil from Croton cajucara. Antimicrobial Agents and Chemotherapy 47:6 (2003), 1895–1901.
87. do Vale, T.G., Furtado, E.C., Santos, J.G. Jr., Viana, G.S., Central effects of citral, myrcene and limonene, constituents of essential oil chemotypes from Lippia alba (Mill.) n.e. Brown. Phytomedicine 9:8 (2002), 709–714.
88. Dong, Y., Li, L., Wang, L., Zhou, T., Liu, J.W., Gao, Y.J., Preliminary study of the effects of beta-elemene on MCF-7/ADM breast cancer stem cells. Genetics and Molecular Research 14:1 (2015), 2347–2355 http://doi.org/10.4238/2015.March.27.20.
89. Douthwaite, A.H., Choice of drugs in the treatment of duodenal ulcer. British Medical Journal 2:4514 (1947), 43–47.
90. Dussy, F.E., Hamberg, C., Luginbuhl, M., Schwerzmann, T., Briellmann, T.A., Isolation of Delta9-THCA-A from hemp and analytical aspects concerning the determination of Delta9-THC in cannabis products. Forensic Science International 149:1 (2005), 3–10.
91. Edman, K., Lofstedt, H., Berg, P., Eriksson, K., Axelsson, S., Bryngelsson, I., et al. Exposure assessment to alpha- and beta-pinene, delta(3)-carene and wood dust in industrial production of wood pellets. The Annals of Occupational Hygiene 47:3 (2003), 219–226.
92. Ee, G.C., Lim, C.K., Rahmat, A., Lee, H.L., Cytotoxic activities of chemical constituents from Mesua daphnifolia. Tropical Biomedicine 22:2 (2005), 99–102.
93. Elisabetsky, E., Marschner, J., Souza, D.O., Effects of linalool on glutamatergic system in the rat cerebral cortex. Neurochemical Research 20:4 (1995), 461–465.
94. Elmann, A., Mordechay, S., Rindner, M., Larkov, O., Elkabetz, M., Ravid, U., Protective effects of the essential oil of Salvia fruticosa and its constituents on astrocytic susceptibility to hydrogen peroxide-induced cell death. Journal of Agricultural and Food Chemistry 57:15 (2009), 6636–6641 http://doi.org/10.1021/jf901162f.
95. ElSohly, H.N., Turner, C.E., Clark, A.M., Eisohly, M.A., Synthesis and antimicrobial activities of certain cannabichromene and cannabigerol related compounds. Journal of Pharmaceutical Sciences 71:12 (1982), 1319–1323.
96. Elsohly, M.A., Turner, C.E., Phoebe, C.H.J., Knapp, J.E., Schiff, P.L.J., Slatkin, D.J., Anhydrocannabisativine, a new alkaloid from Cannabis sativa L. Journal of Pharmaceutical Sciences, 67(1), 1978, 124.
97. Elzinga, S., Fischedick, J., Podkolinski, R., Raber, J.C., Cannabinoid and terpenes as chemotaxonomic markers in cannabis. Natural Products Chemistry & Research 3:4 (2015), 1–9.
98. Evans, F.J., Cannabinoids: The separation of central from peripheral effects on a structural basis. Planta Medica 57:7 (1991), S60–S67.
99. Evans, F.J., Cannabinoids: The separation of central from peripheral effects on a structural basis. Planta Medica 57:S 1 (2007), S60–S67 http://doi.org/10.1055/s-2006-960231.
100. Falk, A.A., Hagberg, M.T., Lof, A.E., Wigaeus-Hjelm, E.M., Wang, Z.P., Uptake, distribution and elimination of alpha-pinene in man after exposure by inhalation. Scandinavian Journal of Work, Environment and Health 16:5 (1990), 372–378.
101. Falk, A., Lof, A., Hagberg, M., Hjelm, E.W., Wang, Z., Human exposure to 3-carene by inhalation: Toxicokinetics, effects on pulmonary function and occurrence of irritative and CNS symptoms. Toxicology and Applied Pharmacology 110:2 (1991), 198–205.
102. Falk-Filipsson, A., Lof, A., Hagberg, M., Hjelm, E.W., Wang, Z., d-limonene exposure to humans by inhalation: Uptake, distribution, elimination, and effects on the pulmonary function. Journal of Toxicology and Environmental Health 38:1 (1993), 77–88.
103. Farag, R.S., Shalaby, A.S., El-Baroty, G.A., Ibrahim, N.A., Ali, M.A., Hassan, E.M., Chemical and biological evaluation of the essential oils of different Melaleuca species. Phytotherapy Research 18:1 (2004), 30–35.
104. Fidyt, K., Fiedorowicz, A., Strządała, L., β-caryophyllene and β-caryophyllene oxide—Natural compounds of anticancer and analgesic properties. Cancer Medicine 5:10 (2016), 3007–3017.
105. 9-tetrahydrocannabinol-producing Cannabis sativa L. cultivars. Cannabis and Cannabinoid Research 2.1 (2017), 34–47, 10.1089/can.2016.0040.
106. Fischedick, J.T., Hazekamp, A., Erkelens, T., Choi, Y.H., Verpoorte, R., Metabolic fingerprinting of Cannabis sativa L., cannabinoids and terpenoids for chemotaxonomic and drug standardization purposes. Phytochemistry 71:17–18 (2010), 2058–2073 http://doi.org/10.1016/j.phytochem.2010.10.001.
107. Fischedick, J., Van Der Kooy, F., Verpoorte, R., Cannabinoid receptor 1 binding activity and quantitative analysis of Cannabis sativa L. smoke and vapor. Chemical & Pharmaceutical Bulletin 58:2 (2010), 201–207.
108. Fitsiou, E., Anestopoulos, I., Chlichlia, K., Galanis, A., Kourkoutas, I., Panayiotidis, M.I., et al. Antioxidant and antiproliferative properties of the essential oils of Satureja thymbra and Satureja parnassica and their major constituents. Anticancer Research 36:11 (2016), 5757–5763, 10.21873/anticanres.11159.
109. Flachenecker, P., Henze, T., Zettl, U.K., Nabiximols (THC/CBD oromucosal spray, Sativex®) in clinical practice—Results of a multicenter, non-interventional study (MOVE 2) in patients with multiple sclerosis spasticity. European Neurology 71:5–6 (2014), 271–279, 10.1159/000357427.
110. Formukong, E.A., Evans, A.T., Evans, F.J., Analgesic and antiinflammatory activity of constituents of Cannabis sativa L. Inflammation 12:4 (1988), 361–371.
111. Franz, C., Novak, J., Sources of essential oils. Baser, K.H.C., Buchbauer, G., (eds.) Handbook of essential oils: Science, technology, and applications, 2010, CRC Press, Boca Raton, FL, 39–82.
112. Fukumoto, S., Morishita, A., Furutachi, K., Terashima, T., Nakayama, T., Yokogoshi, H., Effect of flavour components in lemon essential oil on physical or psychological stress. Stress and Health 24 (2008), 3–12.
113. Gaoni, Y., Mechoulam, R., The structure and function of cannabigerol, a new hashish constituent. Proceedings of the Chemical Society, 1, 1964, 82.
114. Gaoni, Y., Mechoulam, R., Cannabichromene, a new active principle in hashish. Chemical Communications (London) 1 (1966), 20–21 http://doi.org/10.1039/C19660000020.
115. Gattefosse, R.-M. (1993). Gatefosse's aromatherapy (R. W. Tisserand, Trans.). Essex: C.W. Daniel.
116. Gauson, L.A., Stevenson, L.A., Thomas, A., Baillie, G.L., Ross, R.A., Pertwee, R.G., Cannabigerol behaves as a partial agonist at both CB1 and CB2 receptors., Presented at the 17th annual symposium on the cannabinoids, Saint-Sauveur, Quebec, 2007, International Cannabinoid Research Society, Canada, 206.
117. Gertsch, J., Anti-inflammatory cannabinoids in diet: Towards a better understanding of CB(2) receptor action?. Communicative & Integrative Biology 1:1 (2008), 26–28.
118. Ghelardini, C., Galeotti, N., Salvatore, G., Mazzanti, G., Local anaesthetic activity of the essential oil of Lavandula angustifolia. Planta Medica 65:8 (1999), 700–703 http://doi.org/10.1055/s-1999-14045.
119. Giese, M.W., Lewis, M.A., Giese, L., Smith, K.M., Development and validation of a reliable and robust method for the analysis of cannabinoids and terpenes in cannabis. Journal of AOAC International 98:6 (2015), 1503–1522 http://doi.org/10.5740/jaoacint.15-116.
120. Gil, M.L., Jimenez, J., Ocete, M.A., Zarzuelo, A., Cabo, M.M., Comparative study of different essential oils of Bupleurum gibraltaricum Lamarck. Pharmazie 44:4 (1989), 284–287.
121. Girola, N., Figueiredo, C.R., Farias, C.F., Azevedo, R.A., Ferreira, A.K., Teixeira, S.F., et al. Camphene isolated from essential oil of Piper cernuum (Piperaceae) induces intrinsic apoptosis in melanoma cells and displays antitumor activity in vivo. Biochemical and Biophysical Research Communications 467:4 (2015), 928–934 http://doi.org/10.1016/j.bbrc.2015.10.041.
122. Gong, M., Liu, Y., Zhang, J., Gao, Y.J., Zhai, P.P., Su, X., et al. beta-Elemene inhibits cell proliferation by regulating the expression and activity of topoisomerases I and IIalpha in human hepatocarcinoma HepG-2 cells. BioMed Research International, 2015, 2015, 153987 http://doi.org/10.1155/2015/153987.
123. Govindarajan, M., Rajeswary, M., Benelli, G., Delta-Cadinene, Calarene and delta-4-Carene from Kadsura heteroclita essential oil as novel larvicides against malaria, dengue and filariasis mosquitoes. Combinatorial Chemistry & High Throughput Screening 19:7 (2016), 565–571.
124. Govindarajan, M., Rajeswary, M., Hoti, S.L., Bhattacharyya, A., Benelli, G., Eugenol, alpha-pinene and beta-caryophyllene from Plectranthus barbatus essential oil as eco-friendly larvicides against malaria, dengue and Japanese encephalitis mosquito vectors. Parasitology Research 115:2 (2016), 807–815, 10.1007/s00436-015-4809-0.
125. Grassmann, J., Hippeli, S., Spitzenberger, R., Elstner, E.F., The monoterpene terpinolene from the oil of Pinus mugo L. in concert with alpha-tocopherol and beta-carotene effectively prevents oxidation of LDL. Phytomedicine 12:6–7 (2005), 416–423.
126. Grotenhermen, F., Russo, E.B., Zuardi, A.W., Even high doses of oral cannabidiol do not cause THC-like effects in humans. Cannabis and Cannabinoid Research 2.1 (2017), 1–4, 10.1089/can.2016.0036.
127. Grunfeld, Y., Edery, H., Psychopharmacological activity of the active constituents of hashish and some related cannabinoids. Psychopharmacologia 14:3 (1969), 200–210.
128. Grunfeld, E., Gresty, M.A., Relationship between motion sickness, migraine and menstruation in crew members of a “round the world” yacht race. Brain Research Bulletin 47:5 (1998), 433–436.
129. Guy, G.W., Stott, C.G., The development of Sativex- a natural cannabis-based medicine. Mechoulam, R., (eds.) Cannabinoids as therapeutics, 2005, Birkhäuser Verlag, Basel, Switzerland, 231–263.
130. Hampson, A.J., Grimaldi, M., Axelrod, J., Wink, D., Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants. Proceedings of the National Academy of Sciences of the United States of America 95:14 (1998), 8268–8273.
131. Han, H.D., Cho, Y.-J., Cho, S.K., Byeon, Y., Jeon, H.N., Kim, H.-S., et al. Linalool-incorporated nanoparticles as a novel anticancer agent for epithelial ovarian carcinoma. Molecular Cancer Therapeutics 15:4 (2016), 618–627 http://doi.org/10.1158/1535-7163.MCT-15-0733-T.
132. Han, N.R., Moon, P.D., Ryu, K.J., Jang, J.B., Kim, H.M., Jeong, H.J., Beta-eudesmol suppresses allergic reactions via inhibiting mast cell degranulation. Clinical and Experimental Pharmacology and Physiology 44:2 (2017), 257–265, 10.1111/1440-1681.12698.
133. Hanus, L.O., Meyer, S.M., Munoz, E., Taglialatela-Scafati, O., Appendino, G., Phytocannabinoids: A unified critical inventory. Natural Product Reports 33:12 (2016), 1357–1392, 10.1039/c6np00074f.
134. Harris, B., Phytotherapeutic uses of essential oils. Baser, K.H.C., Buchbauer, G., (eds.) Handbook of essential oils: Science, technology, and applications, 2010, CRC Press, Boca Raton, 315–352.
135. Hassan, S.B., Gali-Muhtasib, H., Goransson, H., Larsson, R., Alpha terpineol: A potential anticancer agent which acts through suppressing NF-kappaB signalling. Anticancer Research 30:6 (2010), 1911–1919.
136. Hazekamp, A., Grotenhermen, F., Review on clinical studies with cannabis and cannabinoids 2005-2009. Cannabinoids 5:Special (2010), 1–21.
137. Hazekamp, A., Tejkalová, K., Papadimitriou, S., Cannabis: From cultivar to chemovar II—A metabolomics approach to cannabis classification. Cannabis and Cannabinoid Research 1:1 (2016), 202–215 http://doi.org/10.1089/can.2016.0017.
138. Herkenham, M., Lynn, A.B., Little, M.D., Johnson, M.R., Melvin, L.S., de Costa, B.R., et al. Cannabinoid receptor localization in brain. Proceedings of the National Academy of Sciences of the United States of America 87:5 (1990), 1932–1936.
139. Hill, A.J., Weston, S.E., Jones, N.A., Smith, I., Bevan, S.A., Williamson, E.M., et al. Delta-Tetrahydrocannabivarin suppresses in vitro epileptiform and in vivo seizure activity in adult rats. Epilepsia 51:8 (2010), 1522–1532 http://doi.org/10.1111/j.1528-1167.2010.02523.x.
140. Hillig, K.W., Mahlberg, P.G., A chemotaxonomic analysis of cannabinoid variation in Cannabis (Cannabaceae). American Journal of Botany 91:6 (2004), 966–975 http://doi.org/10.3732/ajb.91.6.966.
141. Hofmann, M.E., Frazier, C.J., Marijuana, endocannabinoids, and epilepsy: Potential and challenges for improved therapeutic intervention. Experimental Neurology 244 (2013), 43–50 http://doi.org/10.1016/j.expneurol.2011.11.047.
142. Holley, J.H., Hadley, K.W., Turner, C.E., Constituents of Cannabis sativa L. XI: Cannabidiol and cannabichromene in samples of known geographical origin. Journal of Pharmaceutical Sciences 64:5 (1975), 892–894.
143. Holland, M.L., Allen, J.D., Arnold, J.C., Interaction of plant cannabinoids with the multidrug transporter ABCC1 (MRP1). European Journal of Pharmacology 591:1–3 (2008), 128–131 http://doi.org/10.1016/j.ejphar.2008.06.079.
144. Hong, P., Liu, Y., Calcitonin gene-related peptide antagonism for acute treatment of migraine: A meta-analysis. The International Journal of Neuroscience 127:1 (2017), 20–27 http://doi.org/10.3109/00207454.2015.1137915.
145. Horváth, B., Mukhopadhyay, P., Haskó, G., Pacher, P., The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications. The American Journal of Pathology 180:2 (2012), 432–442 http://doi.org/10.1016/j.ajpath.2011.11.003.
146. Hsieh, L.C., Hsieh, S.L., Chen, C.T., Chung, J.G., Wang, J.J., Wu, C.C., Induction of alpha-phellandrene on autophagy in human liver tumor cells. The American Journal of Chinese Medicine 43:1 (2015), 121–136 http://doi.org/10.1142/S0192415X15500081.
147. Hsieh, S.L., Li, Y.C., Chang, W.C., Chung, J.G., Hsieh, L.C., Wu, C.C., Induction of necrosis in human liver tumor cells by alpha-phellandrene. Nutrition and Cancer 66:6 (2014), 970–979 http://doi.org/10.1080/01635581.2014.936946.
148. Hu, Z., Wu, H., Li, Y., Hou, Q., Wang, Y., Li, S., et al. Beta-elemene inhibits the proliferation of esophageal squamous cell carcinoma by regulating long noncoding RNA-mediated inhibition of hTERT expression. Anti-Cancer Drugs 26:5 (2015), 531–539 http://doi.org/10.1097/CAD.0000000000000216.
149. Ismail, M., Central properties and chemical composition of Ocimum basilicum essential oil. Pharmaceutical Biology 44:8 (2006), 619–626.
150. Ito, K., Ito, M., The sedative effect of inhaled terpinolene in mice and its structure-activity relationships. Journal of Natural Medicines 67:4 (2013), 833–837 http://doi.org/10.1007/s11418-012-0732-1.
151. Iwata, N., Kitanaka, S., New cannabinoid-like chromane and chromene derivatives from Rhododendron anthopogonoides. Chemical & Pharmaceutical Bulletin 59:11 (2011), 1409–1412.
152. Jeong, J.G., Kim, Y.S., Min, Y.K., Kim, S.H., Low concentration of 3-carene stimulates the differentiation of mouse osteoblastic MC3T3-E1 subclone 4 cells. Phytotherapy Research 22:1 (2008), 18–22 http://doi.org/10.1002/ptr.2247.
153. Jiang, S., Ling, C., Li, W., Jiang, H., Zhi, Q., Jiang, M., Molecular mechanisms of anti-cancer activities of β-elemene: Targeting hallmarks of cancer. Anti-Cancer Agents in Medicinal Chemistry 16:11 (2016), 1426–1434.
154. Jianjun, Q., Song, Z., Yin, L., Jia, Z., Donglei, L., Treatment of chylothorax with elemene. The Thoracic and Cardiovascular Surgeon 56:2 (2008), 103–105 http://doi.org/10.1055/s-2007-965708.
155. Jung, J., Kempf, J., Mahler, H., Weinmann, W., Detection of Delta9-tetrahydrocannabinolic acid A in human urine and blood serum by LC-MS/MS. Journal of Mass Spectrometry 42:3 (2007), 354–360 http://doi.org/10.1002/jms.1167.
156. Kasanen, J.P., Pasanen, A.L., Pasanen, P., Liesivuori, J., Kosma, V.M., Alarie, Y., Evaluation of sensory irritation of delta3-carene and turpentine, and acceptable levels of monoterpenes in occupational and indoor environment. Journal of Toxicology and Environmental Health. Part A 57:2 (1999), 89–114.
157. Kasuya, H., Okada, N., Kubohara, M., Satou, T., Masuo, Y., Koike, K., Expression of BDNF and TH mRNA in the brain following inhaled administration of alpha-pinene. Phytotherapy Research 29:1 (2015), 43–47 http://doi.org/10.1002/ptr.5224.
158. Katsuyama, S., Mizoguchi, H., Kuwahata, H., Komatsu, T., Nagaoka, K., Nakamura, H., et al. Involvement of peripheral cannabinoid and opioid receptors in beta-caryophyllene-induced antinociception. European Journal of Pain (London, England) 17:5 (2013), 664–675 http://doi.org/10.1002/j.1532-2149.2012.00242.x.
159. Kennell, J., A beekeeper has trained bees to make honey from cannabis resin. 2016 Retrieved January 22, 2017, from http://thescienceexplorer.com/nature/beekeeper-has-trained-bees-make-honey-cannabis-resin.
160. Kim, S.S., Baik, J.S., Oh, T.H., Yoon, W.J., Lee, N.H., Hyun, C.G., Biological activities of Korean Citrus obovoides and Citrus natsudaidai essential oils against acne-inducing bacteria. Bioscience, Biotechnology, and Biochemistry 72:10 (2008), 2507–2513.
161. Kim, S., Choi, Y., Choi, S., Choi, Y., Park, T., Dietary camphene attenuates hepatic steatosis and insulin resistance in mice. Obesity (Silver Spring) 22:2 (2014), 408–417 http://doi.org/10.1002/oby.20554.
162. Kim, S.Y., Hwang, J.Y., Shin, U.S., Preparation of nano/macroporous polycaprolactone microspheres for an injectable cell delivery system using room temperature ionic liquid and camphene. Journal of Colloid and Interface Science 465 (2016), 18–25 http://doi.org/10.1016/j.jcis.2015.11.055.
163. Kim, J.T., Ren, C.J., Fielding, G.A., Pitti, A., Kasumi, T., Wajda, M., et al. Treatment with lavender aromatherapy in the post-anesthesia care unit reduces opioid requirements of morbidly obese patients undergoing laparoscopic adjustable gastric banding. Obesity Surgery 17:7 (2007), 920–925.
164. Kimura, Y., Sumiyoshi, M., Effects of an Atractylodes lancea rhizome extract and a volatile component beta-eudesmol on gastrointestinal motility in mice. Journal of Ethnopharmacology 141:1 (2012), 530–536 http://doi.org/10.1016/j.jep.2012.02.031.
165. Kiso, Y., Tohkin, M., Hikino, H., Antihepatotoxic principles of Atractylodes rhizomes. Journal of Natural Products 46:5 (1983), 651–654.
166. Komiya, M., Takeuchi, T., Harada, E., Lemon oil vapor causes an anti-stress effect via modulating the 5-HT and DA activities in mice. Behavioural Brain Research 172:2 (2006), 240–249 http://doi.org/10.1016/j.bbr.2006.05.006.
167. Komori, T., Fujiwara, R., Tanida, M., Nomura, J., Yokoyama, M.M., Effects of citrus fragrance on immune function and depressive states. Neuroimmunomodulation 2:3 (1995), 174–180.
168. Kose, E.O., Deniz, I.G., Sarikurkcu, C., Aktas, O., Yavuz, M., Chemical composition, antimicrobial and antioxidant activities of the essential oils of Sideritis erythrantha Boiss. and Heldr. (var. erythrantha and var. cedretorum P.H. Davis) endemic in Turkey. Food and Chemical Toxicology 48:10 (2010), 2960–2965, 10.1016/j.fct.2010.07.033.
169. Kovac, J., Simunovic, K., Wu, Z., Klancnik, A., Bucar, F., Zhang, Q., et al. Antibiotic resistance modulation and modes of action of (-)-alpha-pinene in Campylobacter jejuni. PloS One, 10(4), 2015, e0122871 http://doi.org/10.1371/journal.pone.0122871.
170. Kowal, M.A., Hazekamp, A., Grotenhermen, F., Review on clinical studies with cannabis and cannabinoids 2010-2014. Cannabinoids 11:Special (2016), 1–18.
171. Krol, S., Namiesnik, J., Zabiegala, B., alpha-Pinene, 3-carene and d-limonene in indoor air of Polish apartments: The impact on air quality and human exposure. The Science of the Total Environment 468–469 (2014), 985–995 http://doi.org/10.1016/j.scitotenv.2013.08.099.
172. Kusuhara, M., Urakami, K., Masuda, Y., Zangiacomi, V., Ishii, H., Tai, S., et al. Fragrant environment with alpha-pinene decreases tumor growth in mice. Biomedical Research 33:1 (2012), 57–61.
173. Lafourcade, M., Larrieu, T., Mato, S., Duffaud, A., Sepers, M., Matias, I., et al. Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. Nature Neuroscience 14:3 (2011), 345–350 http://doi.org/10.1038/nn.2736.
174. Lafuente, H., Alvarez, F.J., Pazos, M.R., Alvarez, A., Rey-Santano, M.C., Mielgo, V., et al. Cannabidiol reduces brain damage and improves functional recovery after acute hypoxia-ischemia in newborn pigs. Pediatric Research 70:3 (2011), 272–277 http://doi.org/10.1203/PDR.0b013e3182276b11.
175. Langenheim, J.H., Higher plant terpenoids: A phytocentric overview of their ecological roles. Journal of Chemical Ecology 20:6 (1994), 1223–1279.
176. Lapczynski, A., Bhatia, S.P., Letizia, C.S., Api, A.M., Fragrance material review on nerolidol (isomer unspecified). Food Chem Toxicol 46:Suppl. 11 (2008), S247–S250, 10.1016/j.fct.2008.06.063 S0278-6915(08)00355-4 [pii].
177. Lapczynski, A., Letizia, C.S., Api, A.M., Addendum to Fragrance material review on linalool. Food and Chemical Toxicology 46:Suppl. 11 (2008), S190–S192.
178. Laprairie, R.B., Bagher, A.M., Kelly, M.E.M., Denovan-Wright, E.M., Cannabidiol is a negative allosteric modulator of the type 1 cannabinoid receptor. British Journal of Pharmacology 172:20 (2015), 4790–4805 http://doi.org/10.1111/bph.13250.
179. Lastbom, L., Boman, A., Johnsson, S., Camner, P., Ryrfeldt, A., Increased airway responsiveness of a common fragrance component, 3-carene, after skin sensitisation—A study in isolated guinea pig lungs. Toxicology Letters 145:2 (2003), 189–196.
180. Lawless, J., The illustrated encyclopedia of essential oils: The complete guide to the use of oils in aromatherapy and herbalism. 1995, Element, Shaftesbury, Dorset, [England]; Rockport, Mass.
181. Leal-Cardoso, J.H., da Silva-Alves, K.S., Ferreira-da-Silva, F.W., dos Santos-Nascimento, T., Joca, H.C., de Macedo, F.H.P., et al. Linalool blocks excitability in peripheral nerves and voltage-dependent Na + current in dissociated dorsal root ganglia neurons. European Journal of Pharmacology 645:1–3 (2010), 86–93.
182. Legault, J., Pichette, A., Potentiating effect of β-caryophyllene on anticancer activity of α-humulene, isocaryophyllene and paclitaxel. Journal of Pharmacy and Pharmacology 59:12 (2007), 1643–1647 http://doi.org/10.1211/jpp.59.12.0005.
183. Li, Q., Li, L., Wang, F., CHEN, J., Zhao, Y., Wang, P., et al. Dietary capsaicin prevents nonalcoholic fatty liver disease through transient receptor potential vanilloid 1-mediated peroxisome proliferator-activated receptor delta activation. Pflügers Archiv: European Journal of Physiology 465:9 (2013), 1303–1316 http://doi.org/10.1007/s00424-013-1274-4.
184. Li, L., Shi, C., Yin, Z., Jia, R., Peng, L., Kang, S., et al. Antibacterial activity of alpha-terpineol may induce morphostructural alterations in Escherichia coli. Brazilian Journal of Microbiology 45:4 (2014), 1409–1413.
185. Lichtman, A.H., Sheikh, S.M., Loh, H.H., Martin, B.R., Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice. Journal of Pharmacology and Experimental Therapeutics 298:3 (2001), 1007–1014.
186. Ligresti, A., Moriello, A.S., Starowicz, K., Matias, I., Pisanti, S., De Petrocellis, L., et al. Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. Journal of Pharmacology and Experimental Therapeutics 318:3 (2006), 1375–1387 http://doi.org/10.1124/jpet.106.105247.
187. Lima, D.F., Brandao, M.S., Moura, J.B., Leitao, J.M., Carvalho, F.A., Miura, L.M., et al. Antinociceptive activity of the monoterpene alpha-phellandrene in rodents: Possible mechanisms of action. Journal of Pharmacy and Pharmacology 64:2 (2012), 283–292 http://doi.org/10.1111/j.2042-7158.2011.01401.x.
188. Lin, W.Y., Kuo, Y.H., Chang, Y.L., Teng, C.M., Wang, E.C., Ishikawa, T., et al. Anti-platelet aggregation and chemical constituents from the rhizome of Gynura japonica. Planta Medica 69:8 (2003), 757–764.
189. Lin, J.J., Lin, J.H., Hsu, S.C., Weng, S.W., Huang, Y.P., Tang, N.Y., et al. Alpha-phellandrene promotes immune responses in normal mice through enhancing macrophage phagocytosis and natural killer cell activities. In Vivo 27:6 (2013), 809–814.
190. Lin, J.J., Wu, C.C., Hsu, S.C., Weng, S.W., Ma, Y.S., Huang, Y.P., et al. Alpha-phellandrene-induced DNA damage and affect DNA repair protein expression in WEHI-3 murine leukemia cells in vitro. Environmental Toxicology 30:11 (2015), 1322–1330 http://doi.org/10.1002/tox.22003.
191. Lin, J.J., Yu, C.C., Lu, K.W., Chang, S.J., Yu, F.S., Liao, C.L., et al. alpha-Phellandrene alters expression of genes associated with DNA damage, cell cycle, and apoptosis in murine leukemia WEHI-3 cells. Anticancer Research 34:8 (2014), 4161–4180.
192. Liu, J.S., Che, X.M., Chang, S., Qiu, G.L., He, S.C., Fan, L., et al. beta-elemene enhances the radiosensitivity of gastric cancer cells by inhibiting Pak1 activation. World Journal of Gastroenterology 21:34 (2015), 9945–9956 http://doi.org/10.3748/wjg.v21.i34.9945.
193. Liu, T., Wang, C.J., Xie, H.Q., Mu, Q., Guaiol-a naturally occurring insecticidal sesquiterpene. Natural Product Communications 8:10 (2013), 1353–1354.
194. Liu, J., Zhang, Z., Gao, J., Xie, J., Yang, L., Hu, S., Downregulation effects of beta-elemene on the levels of plasma endotoxin, serum TNF-alpha, and hepatic CD14 expression in rats with liver fibrosis. Frontiers in Medicine 5:1 (2011), 101–105 http://doi.org/10.1007/s11684-011-0111-4.
195. Lone, J., Yun, J.W., Monoterpene limonene induces brown fat-like phenotype in 3T3-L1 white adipocytes. Life Sciences 153 (2016), 198–206 http://doi.org/10.1016/j.lfs.2016.04.010.
196. Lopes, N.P., Kato, M.J., Andrade, E.H., Maia, J.G., Yoshida, M., Planchart, A.R., et al. Antimalarial use of volatile oil from leaves of Virola surinamensis (Rol.) Warb. by Waiapi Amazon Indians. Journal of Ethnopharmacology 67:3 (1999), 313–319.
197. Lorenzetti, B.B., Souza, G.E., Sarti, S.J., Santos Filho, D., Ferreira, S.H., Myrcene mimics the peripheral analgesic activity of lemongrass tea. Journal of Ethnopharmacology 34:1 (1991), 43–48.
198. Lotter, H.L., Abraham, D.J., Cannabisativine, a new alkaloid from Cannabis sativa L. root. Tetrahedron Letters 16:33 (1975), 2815–2818.
199. Lowette, K., Roosen, L., Tack, J., Berghe, P.V., Effects of high-fructose diets on central appetite signaling and cognitive function. Frontiers in Nutrition 2 (2015), 1–5 http://doi.org/10.3389/fnut.2015.00005/abstract.
200. Macedo, E.M., Santos, W.C., Sousa, B.P.N., Lopes, E.M., Piauilino, C.A., Cunha, F.V., et al. Association of terpinolene and diclofenac presents antinociceptive and anti-inflammatory synergistic effects in a model of chronic inflammation. Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas/Sociedade Brasileira De Biofísica … [Et Al.], 49(7), 2016, 10 http://doi.org/10.1590/1414-431X20165103.
201. Maione, S., Piscitelli, F., Gatta, L., Vita, D., De Petrocellis, L., Palazzo, E., et al. Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action. British Journal of Pharmacology 162:3 (2011), 584–596 http://doi.org/10.1111/j.1476-5381.2010.01063.x.
202. Maisonnasse, A., Lenoir, J.-C., Beslay, D., Crauser, D., Le Conte, Y., E-β-ocimene, a volatile brood pheromone involved in social regulation in the honey bee colony (Apis mellifera). PloS One, 5(10), 2010, e13531 http://doi.org/10.1371/journal.pone.0013531.
203. Maor, Y., Gallily, R., Mechoulam, R., The relevance of the steric factor in the biological activity of CBD derivatives-a tool in identifying novel molecular target for cannabinoids., Presented at the symposium on the cannabinoids, Tihany, 2006, International Cannabinoid Research Society, Hungary, 1.
204. Marcu, J.P., An overview of major and minor phytocannabinoids. Preedy, V.R., (eds.) Neuropathology of drug addictions and substance misuse, 2016, Elsevier Academic Press, Amsterdam; Boston, MA, 672–678 http://doi.org/10.1016/B978-0-12-800213-1.00062-6.
205. Marcu, J.P., Christian, R.T., Lau, D., Zielinski, A.J., Horowitz, M.P., Lee, J., et al. Cannabidiol enhances the inhibitory effects of 9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival. Molecular Cancer Therapeutics 9:1 (2010), 180–189 http://doi.org/10.1158/1535-7163.MCT-09-0407.
206. Martin, B.R., Compton, D.R., Thomas, B.F., Prescott, W.R., Little, P.J., Razdan, R.K., et al. Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs. Pharmacology, Biochemistry, and Behavior 40:3 (1991), 471–478 http://doi.org/10.1016/0091-3057(91)90349-7.
207. Martin-Moreno, A.M., Reigada, D., Ramirez, B.G., Mechoulam, R., Innamorato, N., Cuadrado, A., et al. Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: Relevance to Alzheimer's disease. Molecular Pharmacology 79:6 (2011), 964–973 http://doi.org/10.1124/mol.111.071290.
208. Matsuda, L.A., Lolait, S.J., Brownstein, M.J., Young, A.C., Bonner, T.I., Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:6284 (1990), 561–564 http://doi.org/10.1038/346561a0.
209. McLaughlin, P.J., Reports of the death of CB1 antagonists have been greatly exaggerated. Behavioural Pharmacology 23:5–6 (2012), 537–550 http://doi.org/10.1097/FBP.0b013e3283566a8c.
210. McPartland, J.M., Duncan, M., Di Marzo, V., Pertwee, R.G., Are cannabidiol and Delta(9)-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review. British Journal of Pharmacology 172:3 (2015), 737–753 http://doi.org/10.1111/bph.12944.
211. McPartland, J.M., Guy, G.W., Di Marzo, V., Care and feeding of the endocannabinoid system: A systematic review of potential clinical interventions that upregulate the endocannabinoid system. PloS One, 9(3), 2014, e89566 http://doi.org/10.1371/journal.pone.0089566.
212. McPartland, J.M., Russo, E.B., Cannabis and cannabis extracts: Greater than the sum of their parts?. Journal of Cannabis Therapeutics 1:3–4 (2001), 103–132 http://doi.org/10.1300/J175v01n03_08.
213. McPartland, J.M., Russo, E.B., Non-phytocannabinoid constituents of cannabis and herbal synergy. Handbook of cannabis, 2014.
214. Mechoulam, R., Plant cannabinoids: A neglected pharmacological treasure trove. British Journal of Pharmacology 146:7 (2005), 913–915 http://doi.org/10.1038/sj.bjp.0706415.
215. Mechoulam, R., Feigenbaum, J.J., Lander, N., Segal, M., Järbe, T.U., Hiltunen, A.J., et al. Enantiomeric cannabinoids: Stereospecificity of psychotropic activity. Experientia 44:9 (1988), 762–764.
216. Mechoulam, R., Parker, L.A., Gallily, R., Cannabidiol: An overview of some pharmacological aspects. The Journal of Clinical Pharmacology 42:11 Suppl. (2002), 11S–19S.
217. Mehmedic, Z., Chandra, S., Slade, D., Denham, H., Foster, S., Patel, A.S., et al. Potency trends of Δ9-THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008*. Journal of Forensic Sciences 55:5 (2010), 1209–1217 http://doi.org/10.1111/j.1556-4029.2010.01441.x.
218. Meier, C., Mediavilla, V., Factors influencing the yield and the quality of hemp (Cannabis sativa L.) essential oil. Journal of the International Hemp Association 5:1 (1998), 16–20.
219. Meijer, E.P.M., Hammond, K.M., The inheritance of chemical phenotype in Cannabis sativa L. (II): Cannabigerol predominant plants. Euphytica 145:1–2 (2005), 189–198 http://doi.org/10.1007/s10681-005-1164-8.
220. Meijer, E.P.M., Hammond, K.M., Micheler, M., The inheritance of chemical phenotype in Cannabis sativa L. (III): Variation in cannabichromene proportion. Euphytica 165:2 (2008), 293–311 http://doi.org/10.1007/s10681-008-9787-1.
221. Miller, J.A., Lang, J.E., Ley, M., Nagle, R., Hsu, C.H., Thompson, P.A., et al. Human breast tissue disposition and bioactivity of limonene in women with early-stage breast cancer. Cancer Prevention Research (Philadelphia, Pa.) 6:6 (2013), 577–584 http://doi.org/10.1158/1940-6207.CAPR-12-0452.
222. Miyamoto, T., Okimoto, T., Kuwano, M., Chemical composition of the essential oil of mastic gum and their antibacterial activity against drug-resistant Helicobacter pylori. Natural Products and Bioprospecting 4:4 (2014), 227–231 http://doi.org/10.1007/s13659-014-0033-3.
223. Miyazawa, M., Yamafuji, C., Inhibition of acetylcholinesterase activity by bicyclic monoterpenoids. Journal of Agricultural and Food Chemistry 53:5 (2005), 1765–1768, 10.1021/jf040019b.
224. Moghimi, M., Parvardeh, S., Zanjani, T.M., Ghafghazi, S., Protective effect of alpha-terpineol against impairment of hippocampal synaptic plasticity and spatial memory following transient cerebral ischemia in rats. The Iranian Journal of Basic Medical Sciences 19:9 (2016), 960–969.
225. Moldzio, R., Pacher, T., Krewenka, C., Kranner, B., Novak, J., Duvigneau, J.C., et al. Effects of cannabinoids Δ(9)-tetrahydrocannabinol, Δ(9)-tetrahydrocannabinolic acid and cannabidiol in MPP + affected murine mesencephalic cultures. Phytomedicine 19:8–9 (2012), 819–824 http://doi.org/10.1016/j.phymed.2012.04.002.
226. Moreno-Sanz, G., Can you pass the acid test? Critical review and novel therapeutic perspectives of Δ 9-tetrahydrocannabinolic acid A. Cannabis and Cannabinoid Research 1:1 (2016), 124–130 http://doi.org/10.1089/can.2016.0008.
227. Moreno-Sanz, G., Duranti, A., Melzig, L., Fiorelli, C., Ruda, G.F., Colombano, G., et al. Synthesis and structure–activity relationship studies of O-biphenyl-3-yl carbamates as peripherally restricted fatty acid amide hydrolase inhibitors. Journal of Medicinal Chemistry 56:14 (2013), 5917–5930.
228. Mukerji, G., Yiangou, Y., Corcoran, S.L., Selmer, I.S., Smith, G.D., Benham, C.D., et al. Cool and menthol receptor TRPM8 in human urinary bladder disorders and clinical correlations. BMC Urology, 6, 2006, 6 http://doi.org/10.1186/1471-2490-6-6.
229. Murillo-Rodriguez, E., Millan-Aldaco, D., Palomero-Rivero, M., Mechoulam, R., Drucker-Colin, R., Cannabidiol, a constituent of Cannabis sativa, modulates sleep in rats. FEBS Letters 580:18 (2006), 4337–4345.
230. Musty, R.E., Deyo, R.A., A cannabigerol extract alters behavioral despair in an animal model of depression., Presented at the symposium on the cannabinoids, Tihany, 2006, International Cannabinoid Research Society, Hungary, 32.
231. Musty, R.E., Karniol, I.G., Shirikawa, I., Takahashi, R.N., Knobel, E., Interactions of delta-9-tetrahydrocannabinol and cannabinol in man. The Pharmacology of Marihuana 2 (1976), 559–563.
232. Naef, M., Curatolo, M., Petersen-Felix, S., Arendt-Nielsen, L., Zbinden, A., Brenneisen, R., The analgesic effect of oral delta-9-tetrahydrocannabinol (THC), morphine, and a THC-morphine combination in healthy subjects under experimental pain conditions. Pain 105:1–2 (2003), 79–88.
233. Name Withheld. (2006). Studying the effects of terpenes. O'Shaughnessy's (Spring 2006), 2.
234. Neff, G.W., O'Brien, C.B., Reddy, K.R., Bergasa, N.V., Regev, A., Molina, E., et al. Preliminary observation with dronabinol in patients with intractable pruritus secondary to cholestatic liver disease. The American Journal of Gastroenterology 97:8 (2002), 2117–2119.
235. Nicholson, A.N., Turner, C., Stone, B.M., Robson, P.J., Effect of delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults. Journal of Clinical Psychopharmacology 24:3 (2004), 305–313.
236. Nogueira, M.N., Aquino, S.G., Rossa Junior, C., Spolidorio, D.M., Terpinen-4-ol and alpha-terpineol (tea tree oil components) inhibit the production of IL-1beta, IL-6 and IL-10 on human macrophages. Inflammation Research 63:9 (2014), 769–778 http://doi.org/10.1007/s00011-014-0749-x.
237. Noma, Y., Asakawa, Y., Biotransformation of monoterpenoids by microorganisms, insects, and mammals. Baser, K.H.C., Buchbauer, G., (eds.) Handbook of essential oils: Science, technology, and applications, 2010, CRC Press, Boca Raton, FL, 585–736.
238. Noskova, K., Dovrtelova, G., Zendulka, O., Řemínek, R., Jurica, J., The effect of (-)-linalool on the metabolic activity of liver CYP enzymes in rats. Physiological Research/Academia Scientiarum Bohemoslovaca 65:Suppl. 4 (2016), S499–S504.
239. Okumura, N., Yoshida, H., Nishimura, Y., Kitagishi, Y., Matsuda, S., Terpinolene, a component of herbal sage, downregulates AKT1 expression in K562 cells. Oncology Letters 3:2 (2012), 321–324 http://doi.org/10.3892/ol.2011.491.
240. Onaivi, E.S., Ishiguro, H., Gong, J.-P., Patel, S., Meozzi, P.A., Myers, L., et al. Brain neuronal CB2 cannabinoid receptors in drug abuse and depression: From mice to human subjects. PloS One, 3(2), 2008, e1640 http://doi.org/10.1371/journal.pone.0001640.
241. Onawunmi, G.O., Yisak, W.A., Ogunlana, E.O., Antibacterial constituents in the essential oil of Cymbopogon citratus (DC.) Stapf. Journal of Ethnopharmacology 12:3 (1984), 279–286.
242. Opdyke, D.L.J., Caryophyllene oxide. Food and Chemical Toxicology 21:5 (1983), 661–662.
243. Pacher, P., The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacological Reviews 58:3 (2006), 389–462 http://doi.org/10.1124/pr.58.3.2.
244. Pacher, P., Mechoulam, R., Is lipid signaling through cannabinoid 2 receptors part of a protective system?. Progress in Lipid Research 50:2 (2011), 193–211 http://doi.org/10.1016/j.plipres.2011.01.001.
245. Park, H.M., Lee, J.H., Yaoyao, J., Jun, H.J., Lee, S.J., Limonene, a natural cyclic terpene, is an agonistic ligand for adenosine A(2A) receptors. Biochemical and Biophysical Research Communications 404:1 (2011), 345–348 http://doi.org/10.1016/j.bbrc.2010.11.121.
246. Parker, L.A., Taste avoidance and taste aversion: Evidence for two different processes. Animal Learning & Behavior 31:2 (2003), 165–172.
247. Parvardeh, S., Moghimi, M., Eslami, P., Masoudi, A., Alpha-Terpineol attenuates morphine-induced physical dependence and tolerance in mice: Role of nitric oxide. The Iranian Journal of Basic Medical Sciences 19:2 (2016), 201–208.
248. Paula-Freire, L.I., Andersen, M.L., Gama, V.S., Molska, G.R., Carlini, E.L., The oral administration of trans-caryophyllene attenuates acute and chronic pain in mice. Phytomedicine 21:3 (2014), 356–362 http://doi.org/10.1016/j.phymed.2013.08.006.
249. Peana, A.T., Rubattu, P., Piga, G.G., Fumagalli, S., Boatto, G., Pippia, P., et al. Involvement of adenosine A1 and A2A receptors in (-)-linalool-induced antinociception. Life Sciences 78:21 (2006), 2471–2474 http://doi.org/10.1016/j.lfs.2005.10.025.
250. Peng, X., Zhao, Y., Liang, X., Wu, L., Cui, S., Guo, A., et al. Assessing the quality of RCTs on the effect of beta-elemene, one ingredient of a Chinese herb, against malignant tumors. Contemporary Clinical Trials 27:1 (2006), 70–82 http://doi.org/10.1016/j.cct.2005.07.002.
251. Perry, N.S., Houghton, P.J., Theobald, A., Jenner, P., Perry, E.K., In-vitro inhibition of human erythrocyte acetylcholinesterase by salvia lavandulaefolia essential oil and constituent terpenes. Journal of Pharmacy and Pharmacology 52:7 (2000), 895–902.
252. Pertwee, R.G., The central neuropharmcology of psychotropic cannabinoids. Pharmacology and Therapeutics 36:2–3 (1988), 189–261 http://doi.org/10.1016/0163-7258(88)90106-4.
253. Pertwee, R.G., The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. British Journal of Pharmacology 153:2 (2008), 199–215 http://doi.org/10.1038/sj.bjp.0707442.
254. Pertwee, R.G., Cascio, M.G., Known pharmacological actions of delta-9-tetrahydrocannabinol and of four other chemical constituents of cannabis that activate cannabinoid receptors. Pertwee, R.G., (eds.) Handbook of cannabis, 2014, Oxford University Press, Oxford, UK, 115–136 http://doi.org/10.1093/acprof:oso/9780199662685.003.0006.
255. 2. Pharmacological Reviews 62:4 (2010), 588–631 http://doi.org/10.1124/pr.110.003004.
256. Piccinelli, A.C., Morato, P.N., Dos Santos Barbosa, M., Croda, J., Sampson, J., Kong, X., et al. Limonene reduces hyperalgesia induced by gp120 and cytokines by modulation of IL-1 beta and protein expression in spinal cord of mice. Life Sciences 174 (2017), 28–34 http://doi.org/10.1016/j.lfs.2016.11.017.
257. Piccinelli, A.C., Santos, J.A., Konkiewitz, E.C., Oesterreich, S.A., Formagio, A.S., Croda, J., et al. Antihyperalgesic and antidepressive actions of (R)-(+)-limonene, alpha-phellandrene, and essential oil from Schinus terebinthifolius fruits in a neuropathic pain model. Nutritional Neuroscience 18:5 (2015), 217–224 http://doi.org/10.1179/1476830514Y.0000000119.
258. Plengsuriyakarn, T., Karbwang, J., Na-Bangchang, K., Anticancer activity using positron emission tomography-computed tomography and pharmacokinetics of beta-eudesmol in human cholangiocarcinoma xenografted nude mouse model. Clinical and Experimental Pharmacology and Physiology 42:3 (2015), 293–304 http://doi.org/10.1111/1440-1681.12354.
259. Potter, D.J., The propagation, characterisation and optimisation of Cannabis sativa L. as a phytopharmaceutical. Pharmaceutical Sciences. 2009, King's College, London, 224.
260. Pultrini Ade, M., Galindo, L.A., Costa, M., Effects of the essential oil from Citrus aurantium L. in experimental anxiety models in mice. Life Sciences 78:15 (2006), 1720–1725 http://doi.org/10.1016/j.lfs.2005.08.004.
261. Qin, N., Neeper, M.P., Liu, Y., Hutchinson, T.L., Lubin, M.L., Flores, C.M., TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 28:24 (2008), 6231–6238, 10.1523/JNEUROSCI.0504-08.2008 28/24/6231 [pii].
262. Quintans-Junior, L., Moreira, J.C., Pasquali, M.A., Rabie, S.M., Pires, A.S., Schroder, R., et al. Antinociceptive activity and redox profile of the monoterpenes (+)-camphene, p-cymene, and geranyl acetate in experimental models. ISRN Toxicology, 2013, 2013, 459530 http://doi.org/10.1155/2013/459530.
263. Quintans-Junior, L.J., Oliveira, M.G., Santana, M.F., Santana, M.T., Guimaraes, A.G., Siqueira, J.S., et al. Alpha-terpineol reduces nociceptive behavior in mice. Pharmaceutical Biology 49:6 (2011), 583–586 http://doi.org/10.3109/13880209.2010.529616.
264. Ramalho, T.R., Pacheco de Oliveira, M.T., Lima, A.L., Bezerra-Santos, C.R., Piuvezam, M.R., Gamma-terpinene modulates acute inflammatory response in mice. Planta Medica 81:14 (2015), 1248–1254 http://doi.org/10.1055/s-0035-1557790.
265. Raman, A., Weir, U., Bloomfield, S.F., Antimicrobial effects of tea-tree oil and its major components on Staphylococcus aureus, Staph. epidermidis and Propionibacterium acnes. Letters in Applied Microbiology 21:4 (1995), 242–245.
266. Rao, V.S., Menezes, A.M., Viana, G.S., Effect of myrcene on nociception in mice. The Journal of Pharmacy and Pharmacology 42:12 (1990), 877–878.
267. Re, L., Barocci, S., Sonnino, S., Mencarelli, A., Vivani, C., Paolucci, G., et al. Linalool modifies the nicotinic receptor–ion channel kinetics at the mouse neuromuscular junction. Pharmacological Research 42:2 (2000), 177–181 http://doi.org/10.1006/phrs.2000.0671.
268. Reagan-Shaw, S., Nihal, M., Ahmad, N., Dose translation from animal to human studies revisited. The FASEB Journal 22:3 (2008), 659–661 http://doi.org/10.1096/fj.07-9574LSF.
269. Rhee, Man-Hee, Vogel, Zvi, Barg, Jacob, Bayewitch, Michael, Levy, Rivka, Hanuš, Lumir, et al. Cannabinol derivatives: Binding to cannabinoid receptors and inhibition of adenylylcyclase. Journal of Medicinal Chemistry 40:20 (1997), 3228–3233 http://doi.org/10.1021/jm970126f.
270. Riedel, G., Fadda, P., McKillop-Smith, S., Pertwee, R.G., Platt, B., Robinson, L., Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice. British Journal of Pharmacology 156:7 (2009), 1154–1166 http://doi.org/10.1111/j.1476-5381.2008.00107.x.
271. Rivas da Silva, A.C., Lopes, P.M., Barros de Azevedo, M.M., Costa, D.C., Alviano, C.S., Alviano, D.S., Biological activities of alpha-pinene and beta-pinene enantiomers. Molecules (Basel, Switzerland) 17:6 (2012), 6305–6316 http://doi.org/10.3390/molecules17066305.
272. Robson, P., Abuse potential and psychoactive effects of delta-9-tetrahydrocannabinol and cannabidiol oromucosal spray (Sativex), a new cannabinoid medicine. Expert Opinion on Drug Safety 10:5 (2011), 675–685, 10.1517/14740338.2011.575778.
273. Rock, E.M., Kopstick, R.L., Limebeer, C.L., Parker, L.A., Tetrahydrocannabinolic acid reduces nausea-induced conditioned gaping in rats and vomiting in Suncus murinus. British Journal of Pharmacology 170:3 (2013), 641–648 http://doi.org/10.1111/bph.12316.
274. 9-tetrahydrocannabinol in the regulation of emesis in the Suncus murinus (house musk shrew). Behavioral Neuroscience 129:3 (2015), 368–370 http://doi.org/10.1037/bne0000057.
275. Rock, E.M., Sticht, M.A., Parker, L.A., Effect of phytocannabinoids on nausea and vomiting. Pertwee, R.G., (eds.) Handbook of cannabis, 2014, Oxford University Press, Oxford, UK, 435–454 http://doi.org/10.1093/acprof:oso/9780199662685.003.0023.
276. Rodrigues Goulart, H., Kimura, E.A., Peres, V.J., Couto, A.S., Aquino Duarte, F.A., Katzin, A.M., Terpenes arrest parasite development and inhibit biosynthesis of isoprenoids in Plasmodium falciparum. Antimicrobial Agents and Chemotherapy 48:7 (2004), 2502–2509.
277. Rodrigues, K.A., Amorim, L.V., Dias, C.N., Moraes, D.F., Carneiro, S.M., Carvalho, F.A., Syzygium cumini (L.) Skeels essential oil and its major constituent alpha-pinene exhibit anti-Leishmania activity through immunomodulation in vitro. Journal of Ethnopharmacology 160 (2015), 32–40 http://doi.org/10.1016/j.jep.2014.11.024.
278. Rog, D.J., Nurmiko, T., Friede, T., Young, C., Randomized controlled trial of cannabis based medicine in central neuropathic pain due to multiple sclerosis. Neurology 65:6 (2005), 812–819.
279. Romano, B., Borrelli, F., Fasolino, I., Capasso, R., Piscitelli, F., Cascio, M., et al. The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis. British Journal of Pharmacology 169:1 (2013), 213–229 http://doi.org/10.1111/bph.12120.
280. Rosenthaler, S., Pöhn, B., Kolmanz, C., Huu, C.N., Krewenka, C., Huber, A., et al. Differences in receptor binding affinity of several phytocannabinoids do not explain their effects on neural cell cultures. Neurotoxicology and Teratology 46 (2014), 49–56 http://doi.org/10.1016/j.ntt.2014.09.003.
281. Rufino, A.T., Ribeiro, M., Sousa, C., Judas, F., Salgueiro, L., Cavaleiro, C., et al. Evaluation of the anti-inflammatory, anti-catabolic and pro-anabolic effects of E-caryophyllene, myrcene and limonene in a cell model of osteoarthritis. European Journal of Pharmacology 750 (2015), 141–150 http://doi.org/10.1016/j.ejphar.2015.01.018.
282. Russo, E.B., Handbook of psychotropic herbs: A scientific analysis of herbal remedies for psychiatric conditions. 2001, Haworth Press, Binghamton, NY.
283. Russo, E.B., History of cannabis and its preparations in saga, science, and sobriquet. Chemistry & Biodiversity 4:8 (2007), 1614–1648.
284. Russo, E.B., Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology 163:7 (2011), 1344–1364 http://doi.org/10.1111/j.1476-5381.2011.01238.x.
285. Russo, E.B., Cannabis strains: Do cannabis strains differ?. Retrieved January 18, 2017, from http://www.cannabis-med.org/index.php?tpl=faq&red=faqlist&id=278&lng=en, 2013.
286. Russo, E.B., The pharmacological history of Cannabis. Pertwee, R., (eds.) Handbook of Cannabinoids, 2014, Oxford University Press, Oxford, United Kingdom, 23–43.
287. Russo, E.B., Beyond cannabis: Plants and the endocannabinoid system. Trends in Pharmacological Sciences 37:7 (2016), 594–605, 10.1016/j.tips.2016.04.005.
288. Russo, E.B., Cannabis and epilepsy: An ancient treatment returns to the fore. Epilepsy and Behavior, 2016, 10.1016/j.yebeh.2016.09.040.
289. Russo, E.B., Cannabis and epilepsy: An ancient treatment returns to the fore. Epilepsy Behav 70:Pt B (2017), 292–297, 10.1016/j.yebeh.2016.09.040.
290. Russo, E.B., Burnett, A., Hall, B., Parker, K.K., Agonistic properties of cannabidiol at 5-HT-1a receptors. Neurochemical Research 30:8 (2005), 1037–1043.
291. Russo, E.B., Guy, G.W., A tale of two cannabinoids: The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol. Medical Hypotheses 66:2 (2006), 234–246, 10.1016/j.mehy.2005.08.026.
292. Russo, E.B., Guy, G.W., Robson, P.J., Cannabis, pain, and sleep: Lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine. Chemistry & Biodiversity 4:8 (2007), 1729–1743 http://doi.org/10.1002/cbdv.200790150.
293. Russo, E.B., Hohmann, A.G., Role of cannabinoids in pain management. Comprehensive treatment of chronic pain by medical, interventional, and integrative approaches, 2012, Springer New York, New York, NY, 181–197 http://doi.org/10.1007/978-1-4614-1560-2_18.
294. Sastre-Garriga, J., Vila, C., Clissold, S., Montalban, X., THC and CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis. Expert Review of Neurotherapeutics 11:5 (2011), 627–637, 10.1586/ern.11.47.
295. Sanguinetti, M., Posteraro, B., Romano, L., Battaglia, F., Lopizzo, T., De Carolis, E., et al. In vitro activity of Citrus bergamia (bergamot) oil against clinical isolates of dermatophytes. The Journal of Antimicrobial Chemotherapy 59:2 (2007), 305–308 http://doi.org/10.1093/jac/dkl473.
296. Satou, T., Kasuya, H., Maeda, K., Koike, K., Daily inhalation of alpha-pinene in mice: Effects on behavior and organ accumulation. Phytotherapy Research 28:9 (2014), 1284–1287.
297. Sayyah, M., Nadjafnia, L., Kamalinejad, M., Anticonvulsant activity and chemical composition of Artemisia dracunculus L. essential oil. Journal of Ethnopharmacology 94:2–3 (2004), 283–287.
298. Scuderi, C., De Filippis, D., Iuvone, T., Blasio, A., Steardo, A., Esposito, G., Cannabidiol in medicine: A review of its therapeutic potential in CNS disorders. Phytotherapy Research 23:5 (2009), 597–602 http://doi.org/10.1002/ptr.2625.
299. Schafer, D., Schafer, W., Pharmacological studies with an ointment containing menthol, camphene and essential oils for broncholytic and secretolytic effects. Arzneimittel-Forschung 31:1 (1981), 82–86.
300. Schmidt, L., Belov, V.N., Goen, T., Human metabolism of Delta3-carene and renal elimination of Delta3-caren-10-carboxylic acid (chaminic acid) after oral administration. Archives of Toxicology 89:3 (2015), 381–392 http://doi.org/10.1007/s00204-014-1251-5.
301. Schnaubelt, K., Advanced aromatherapy: The science of essential oil therapy. 1st ed., 1998, Healing Arts Press, Rochester, VT.
302. Schott, M., Klein, B., Vilcinskas, A., Detection of illicit drugs by trained honeybees (Apis mellifera). PloS One, 10(6), 2015, e0128528 http://doi.org/10.1371/journal.pone.0128528.
303. Scutt, A., Williamson, E.M., Cannabinoids stimulate fibroblastic colony formation by bone marrow cells indirectly via CB2 receptors. Calcified Tissue International 80:1 (2007), 50–59 http://doi.org/10.1007/s00223-006-0171-7.
304. Sellers, E.M., Schoedel, K., Bartlett, C., Romach, M., Russo, E.B., Stott, C.G., et al. A multiple-dose, randomized, double-blind, placebo-controlled, parallel-group QT/QTc study to evaluate the electrophysiologic effects of THC/CBD spray. Clinical Pharmacology in Drug Development 2:3 (2013), 285–294 http://doi.org/10.1002/cpdd.36.
305. Semenya, S., Potgieter, M., Tshisikhawe, M., Shava, S., Maroyi, A., Medicinal utilization of exotic plants by Bapedi traditional healers to treat human ailments in Limpopo province, South Africa. Journal of Ethnopharmacology 144:3 (2012), 646–655 http://doi.org/10.1016/j.jep.2012.10.005.
306. Sharma, C., Al Kaabi, J.M., Nurulain, S.M., Goyal, S.N., Kamal, M.A., Ojha, S., Polypharmacological properties and therapeutic potential of β-caryophyllene: A dietary phytocannabinoid of pharmaceutical promise. Current Pharmaceutical Design 22:21 (2016), 3237–3264.
307. Shelly, T.E., Nishimoto, J.I., Exposure to the plant compound {alpha} -humulene reduces mating success in male Mediterranean fruit flies (Diptera: Tephritidae). Annals of the Entomological Society of America 108:3 (2015), 215–221 http://doi.org/10.1093/aesa/sav008.
308. Shinjyo, N., Di Marzo, V., The effect of cannabichromene on adult neural stem/progenitor cells. Neurochemistry International 63:5 (2013), 432–437 http://doi.org/10.1016/j.neuint.2013.08.002.
309. Shoyama, Y., Hirano, H., Makino, H., Umekita, N., Nishioka, I., Cannabis. X. The isolation and structures of four new propyl cannabinoid acids, tetrahydrocannabivarinic acid, cannabidivarinic acid, cannabichromevarinic acid and cannabigerovarinic acid, from Thai Cannabis, ‘Meao variant’. Chemical & Pharmaceutical Bulletin 25:9 (1977), 2306–2311 http://doi.org/10.1248/cpb.25.2306.
310. Silva Brum, L.F., Emanuelli, T., Souza, D.O., Elisabetsky, E., Effects of linalool on glutamate release and uptake in mouse cortical synaptosomes. Neurochemical Research 26:3 (2001), 191–194.
311. Singh, P., Shukla, R., Prakash, B., Kumar, A., Singh, S., Mishra, P.K., et al. Chemical profile, antifungal, antiaflatoxigenic and antioxidant activity of Citrus maxima Burm. and Citrus sinensis (L.) Osbeck essential oils and their cyclic monoterpene, DL-limonene. Food and Chemical Toxicology 48:6 (2010), 1734–1740 http://doi.org/10.1016/j.fct.2010.04.001.
312. Siqueira, H.D., Neto, B.S., Sousa, D.P., Gomes, B.S., da Silva, F.V., Cunha, F.V., et al. alpha-Phellandrene, a cyclic monoterpene, attenuates inflammatory response through neutrophil migration inhibition and mast cell degranulation. Life Sciences 160 (2016), 27–33 http://doi.org/10.1016/j.lfs.2016.07.008.
313. Sirikantaramas, S., Morimoto, S., Shoyama, Y., Ishikawa, Y., Wada, Y., Shoyama, Y., et al. The gene controlling marijuana psychoactivity: Molecular cloning and heterologous expression of delta1-tetrahydrocannabinolic acid synthase from Cannabis sativa L. The Journal of Biological Chemistry 279:38 (2004), 39767–39774.
314. Slatkin, D.J., Doorenbos, N.J., Harris, L.S., Masoud, A.N., Quimby, M.W., Schiff, P.L.J., Chemical constituents of Cannabis sativa L. root. Journal of Pharmaceutical Sciences 60:12 (1971), 1891–1892.
315. Slatkin, D.J., Knapp, J.E., Schiff, P.L.J., Turner, C.E., Mole, L.M.J., Steroids of Cannabis sativa root. Phytochemistry 14 (1975), 580–581.
316. Soni, D., Smoum, R., Breuer, A., Mechoulam, R., Steinberg, D., Effect of the synthetic cannabinoid HU-210 on quorum sensing and on the production of quorum sensing-mediated virulence factors by Vibrio harveyi. BMC Microbiology, 15, 2015, 159 http://doi.org/10.1186/s12866-015-0499-0.
317. Stahl, E., Kunde, R., Die Leitsubstanzen der Haschisch-Suchhunde. Kriminalistik: Zeitschrift Für Die Gesamte Kriminalistische Wissenschaft Und Praxis 27:9 (1973), 385–389.
318. Stott, C.G., Guy, G.W., Wright, S., Whittle, B.A., The effects of cannabis extracts Tetranabinex and Nabidiolex on human cytochrome P450-mediated metabolism., Presented at the symposium on the cannabinoids, 2005, International Cannabinoid Research Association, Clearwater, FL, 163.
319. Subramenium, G.A., Vijayakumar, K., Pandian, S.K., Limonene inhibits streptococcal biofilm formation by targeting surface-associated virulence factors. Journal of Medical Microbiology 64:8 (2015), 879–890 http://doi.org/10.1099/jmm.0.000105.
320. Sulak, D., Saneto, R., Goldstein, B., The current status of artisanal cannabis for the treatment of epilepsy in the United States. Epilepsy Behav 70:Pt B (2017), 328–333, 10.1016/j.yebeh.2016.12.032.
321. Sunil, C., Duraipandiyan, V., Ignacimuthu, S., Al-Dhabi, N.A., Antioxidant, free radical scavenging and liver protective effects of friedelin isolated from Azima tetracantha Lam. leaves. Food Chemistry 139:1–4 (2013), 860–865 http://doi.org/10.1016/j.foodchem.2012.12.041.
322. Swift, W., Wong, A., Li, K.M., Arnold, J.C., McGregor, I.S., Analysis of cannabis seizures in NSW, Australia: Cannabis potency and cannabinoid profile. PloS One, 8(7), 2013, e70052 http://doi.org/10.1371/journal.pone.0070052.
323. Takeda, S., Misawa, K., Yamamoto, I., Watanabe, K., Cannabidiolic acid as a selective cyclooxygenase-2 inhibitory component in cannabis. Drug Metabolism and Disposition 36:9 (2008), 1917–1921 http://doi.org/10.1124/dmd.108.020909.
324. Takemoto, H., Ito, M., Shiraki, T., Yagura, T., Honda, G., Sedative effects of vapor inhalation of agarwood oil and spikenard extract and identification of their active components. Journal of Natural Medicines 62:1 (2008), 41–46 http://doi.org/10.1007/s11418-007-0177-0.
325. Tambe, Y., Tsujiuchi, H., Honda, G., Ikeshiro, Y., Tanaka, S., Gastric cytoprotection of the non-steroidal anti-inflammatory sesquiterpene, beta-caryophyllene. Planta Medica 62:5 (1996), 469–470.
326. Thomas, A., Baillie, G.L., Phillips, A.M., Razdan, R.K., Ross, R.A., Pertwee, R.G., Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro. British Journal of Pharmacology 150:5 (2007), 613–623 http://doi.org/10.1038/sj.bjp.0707133.
327. Tisserand, R., Young, R., Essential oil safety. 2nd ed., 2014, Churchill Livingstone Elsevier, Edinburgh, UK.
328. Torres, S., Lorente, M., Rodriguez-Fornes, F., Hernandez-Tiedra, S., Salazar, M., Garcia-Taboada, E., et al. A combined preclinical therapy of cannabinoids and temozolomide against glioma. Molecular Cancer Therapeutics 10:1 (2011), 90–103 http://doi.org/10.1158/1535-7163.MCT-10-0688.
329. Turkez, H., Aydin, E., Geyikoglu, F., Cetin, D., Genotoxic and oxidative damage potentials in human lymphocytes after exposure to terpinolene in vitro. Cytotechnology 67:3 (2015), 409–418 http://doi.org/10.1007/s10616-014-9698-z.
330. Turkez, H., Sozio, P., Geyikoglu, F., Tatar, A., Hacimuftuoglu, A., Di Stefano, A., Neuroprotective effects of farnesene against hydrogen peroxide-induced neurotoxicity in vitro. Cellular and Molecular Neurobiology 34:1 (2014), 101–111 http://doi.org/10.1007/s10571-013-9991-y.
331. Turner, C.E., Elsohly, M.A., Boeren, E.G., Constituents of Cannabis sativa L. XVII. A review of the natural constituents. Journal of Natural Products 43:2 (1980), 169–234.
332. Turner, C.E., Hsu, M.H., Knapp, J.E., Schiff, P.L.J., Slatkin, D.J., Isolation of cannabisativine, an alkaloid, from Cannabis sativa L. root. Journal of Pharmaceutical Sciences 65:7 (1976), 1084–1085.
333. Upton, R., Craker, L., ElSohly, M., Romm, A., Russo, E., Sexton, M., Cannabis inflorescence: Cannabis spp.: Standards of identity, analysis and quality control. Upton, R., (eds.), 2013, American Herbal Pharmacopoeia, Scotts Valley, CA, USA.
334. Vallianou, I., Hadzopoulou-Cladaras, M., Camphene, a plant derived monoterpene, exerts its hypolipidemic action by affecting SREBP-1 and MTP expression. PloS One, 11(1), 2016, e0147117 http://doi.org/10.1371/journal.pone.0147117.
335. Vallianou, I., Peroulis, N., Pantazis, P., Hadzopoulou-Cladaras, M., Camphene, a plant-derived monoterpene, reduces plasma cholesterol and triglycerides in hyperlipidemic rats independently of HMG-CoA reductase activity. PloS One, 6(11), 2011, e20516 http://doi.org/10.1371/journal.pone.0020516.
336. Varga, Z.V., Matyas, C., Erdelyi, K., Cinar, R., Nieri, D., Chicca, A., et al. Beta-caryophyllene protects against alcoholic steatohepatitis by attenuating inflammation and metabolic dysregulation in mice. British Journal of Pharmacology, 2017, 10.1111/bph.13722.
337. Verhoeckx, K.C., Korthout, H.A., van Meeteren-Kreikamp, A.P., Ehlert, K.A., Wang, M., van der Greef, J., et al. Unheated Cannabis sativa extracts and its major compound THC-acid have potential immuno-modulating properties not mediated by CB1 and CB2 receptor coupled pathways. International Immunopharmacology 6:4 (2006), 656–665 http://doi.org/10.1016/j.intimp.2005.10.002.
338. Vigushin, D.M., Poon, G.K., Boddy, A., English, J., Halbert, G.W., Pagonis, C., et al. Phase I and pharmacokinetic study of D-limonene in patients with advanced cancer. Cancer Research Campaign Phase I/II Clinical Trials Committee. Cancer Chemotherapy and Pharmacology 42:2 (1998), 111–117.
339. Volicer, L., Stelly, M., Morris, J., McLaughlin, J., Volicer, B.J., Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer's disease. International Journal of Geriatric Psychiatry 12:9 (1997), 913–919.
340. Von Burg, R., Toxicology update. Limonene. Journal of Applied Toxicology 15:6 (1995), 495–499.
341. Wattenberg, L.W., Inhibition of azoxymethane-induced neoplasia of the large bowel by 3-hydroxy-3,7,11-trimethyl-1,6,10-dodecatriene (nerolidol). Carcinogenesis 12:1 (1991), 151–152.
342. Wade, D.T., Collin, C., Stott, C., Duncombe, P., Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis. Multiple Sclerosis 16:6 (2010), 707–714, 10.1177/1352458510367462 16/6/707 [pii].
343. Werz, O., Seegers, J., Schaible, A.M., Weinigel, C., Barz, D., Koeberle, A., et al. Cannflavins from hemp sprouts, a novel cannabinoid-free hemp food product, target microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase. Pharma Nutrition 2:3 (2014), 53–60 http://doi.org/10.1016/j.phanu.2014.05.001.
344. Wilkinson, J.D., Williamson, E.M., Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis. Journal of Dermatological Science 45:2 (2007), 87–92.
345. Williams, S.J., Hartley, J.P., Graham, J.D., Bronchodilator effect of delta1-tetrahydrocannabinol administered by aerosol of asthmatic patients. Thorax 31:6 (1976), 720–723.
346. Williams, C.M., Jones, N.A., Whalley, B.J., Cannabis and epilepsy. Handbook of cannabis, 2014, Oxford University Press, Oxford, UK, 547–563 http://doi.org/10.1093/acprof:oso/9780199662685.003.0030.
347. Wood, T.B., Spivey, W.T.N., Easterfield, T.H., III.—Cannabinol. Part I. Journal of the Chemical Society, Transactions 75 (1899), 20–36 http://doi.org/10.1039/CT8997500020.
348. Wu, L., Wang, G., Tang, S., Long, G., Yin, T., Protection of endothelial cells, inhibition of neointimal hyperplasia by beta-elemene in an injured artery. Cardiovascular Drugs and Therapy 25:3 (2011), 233–242 http://doi.org/10.1007/s10557-011-6305-9.
349. Wu, X.S., Xie, T., Lin, J., Fan, H.Z., Huang-Fu, H.J., Ni, L.F., et al. An investigation of the ability of elemene to pass through the blood-brain barrier and its effect on brain carcinomas. Journal of Pharmacy and Pharmacology 61:12 (2009), 1653–1656 http://doi.org/10.1211/jpp/61.12.0010.
350. Xi, Z.-X., Peng, X.-Q., Li, X., Song, R., Zhang, H.-Y., Liu, Q.-R., et al. Brain cannabinoid CB2 receptors modulate cocaine's actions in mice. Nature Neuroscience 14:9 (2011), 1160–1166 http://doi.org/10.1038/nn.2874.
351. Xu, H.B., Zheng, L.P., Li, L., Xu, L.Z., Fu, J., Elemene, one ingredient of a Chinese herb, against malignant tumors: A literature-based meta-analysis. Cancer Investigation 31:2 (2013), 156–166 http://doi.org/10.3109/07357907.2012.756108.
352. Yamaori, S., Koeda, K., Kushihara, M., Hada, Y., Yamamoto, I., Watanabe, K., Comparison in the in vitro inhibitory effects of major phytocannabinoids and polycyclic aromatic hydrocarbons contained in marijuana smoke on cytochrome P450 2C9 activity. Drug Metabolism and Pharmacokinetics 27:3 (2012), 294–300 http://doi.org/10.2133/dmpk.DMPK-11-RG-107.
353. Yamaori, S., Kushihara, M., Yamamoto, I., Watanabe, K., Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform-selective and potent inhibitors of human CYP1 enzymes. Biochemical Pharmacology 79:11 (2010), 1691–1698 http://doi.org/10.1016/j.bcp.2010.01.028.
354. Yamaori, S., Okamoto, Y., Yamamoto, I., Watanabe, K., Cannabidiol, a major phytocannabinoid, as a potent atypical inhibitor for CYP2D6. Drug Metabolism and Disposition 39:11 (2011), 2049–2056 http://doi.org/10.1124/dmd.111.041384.
355. Yang, D., Michel, L., Chaumont, J.P., Millet-Clerc, J., Use of caryophyllene oxide as an antifungal agent in an in vitro experimental model of onychomycosis. Mycopathologia 148:2 (1999), 79–82.
356. Yang, H.H., Son, J.K., Jung, B., Zheng, M., Kim, J.R., Epifriedelanol from the root bark of Ulmus davidiana inhibits cellular senescence in human primary cells. Planta Medica 77:5 (2011), 441–449 http://doi.org/10.1055/s-0030-1250458.
357. Yang, Q., Wu, J., Luo, Y., Huang, N., Zhen, N., Zhou, Y., et al. (-)-Guaiol regulates RAD51 stability via autophagy to induce cell apoptosis in non-small cell lung cancer. Oncotarget 7:38 (2016), 62585–62597 http://doi.org/10.18632/oncotarget.11540.
358. Yeshurun, M., Shpilberg, O., Herscovici, C., Shargian, L., Dreyer, J., Peck, A., et al. Cannabidiol for the prevention of graft-versus-host-disease after allogeneic hematopoietic cell transplantation: Results of a phase II study. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 21:10 (2015), 1770–1775 http://doi.org/10.1016/j.bbmt.2015.05.018.
359. Zanoli, P., Zavatti, M., Pharmacognostic and pharmacological profile of Humulus lupulus L. Journal of Ethnopharmacology 116:3 (2008), 383–396 http://doi.org/10.1016/j.jep.2008.01.011.
360. Zhang, J., Zhang, H.D., Yao, Y.F., Zhong, S.L., Zhao, J.H., Tang, J.H., beta-elemene reverses chemoresistance of breast cancer cells by reducing resistance transmission via exosomes. Cellular Physiology and Biochemistry 36:6 (2015), 2274–2286 http://doi.org/10.1159/000430191.
361. Zhou, Y.Y., Liu, H.X., Jiang, N., Feng, X.H., Feng, X.Y., Zhang, H.Q., et al. Elemene, the essential oil of Curcuma wenyujin, inhibits osteogenic differentiation in ankylosing spondylitis. Joint, Bone, Spine 82:2 (2015), 100–103 http://doi.org/10.1016/j.jbspin.2014.05.004.
362. Zhu, T., Li, X., Luo, L., Wang, X., Li, Z., Xie, P., et al. Reversion of malignant phenotypes of human glioblastoma cells by beta-elemene through beta-catenin-mediated regulation of stemness-, differentiation- and epithelial-to-mesenchymal transition-related molecules. Journal of Translational Medicine, 13, 2015, 356 http://doi.org/10.1186/s12967-015-0727-2.
363. Zou, K., Liu, C., Zhang, Z., Zou, L., The effect of elemene on lung adenocarcinoma A549 cell radiosensitivity and elucidation of its mechanism. Clinics (São Paulo, Brazil) 70:8 (2015), 556–562 http://doi.org/10.6061/clinics/2015(08)05.
364. Zou, S., Wang, C., Cui, Z., Guo, P., Meng, Q., Shi, X., et al. Beta-elemene induces apoptosis of human rheumatoid arthritis fibroblast-like synoviocytes via reactive oxygen species-dependent activation of p38 mitogen-activated protein kinase. Pharmacological Reports 68:1 (2016), 7–11 http://doi.org/10.1016/j.pharep.2015.06.004.